Amplius Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Amplius Wealth Advisors’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-108	Closed	-$27K	–	475
2021 Q4	$27K	Buy	+108	New	+$26.4K	﹤0.01%	419

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Amplius Wealth Advisors's HCA Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of HCA Healthcare (HCA) in Q1 2022, closing a stake of 108 shares — an estimated $27K sold.

Amplius Wealth Advisors first reported a position in HCA in Q4 2021 and held it in 1 quarter. The position peaked at $27K in Q4 2021. 968 funds tracked by Wall St. Rank hold HCA as of Q1 2022.

Amplius Wealth Advisors reported no remaining HCA Healthcare position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 108 HCA Healthcare shares in Q1 2022, an estimated $27K.
Amplius Wealth Advisors first reported a position in HCA Healthcare in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's HCA Healthcare position peaked at $27K in Q4 2021.
968 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.